Market Place
Sourcing Support
Delsitech Announces a Major Licensing Agreement on Drug Delivery
23 May 2024 //
PR NEWSWIRE
DelSiTech and Tolmar Announce Global License and Development Agreement
13 Feb 2024 //
PR NEWSWIRE
DelSiTech Announces Closing of EUR 10 Million Financing Round
16 Jan 2024 //
PR NEWSWIRE
DelSiTech announces +ve topline datafrom ph1 trial with its SR eye drop platform
29 Jun 2023 //
PR NEWSWIRE
DelSiTech Awarded a Grant to Develop Injectables for Prophylactic HIV Vaccine
15 Mar 2023 //
PR NEWSWIRE
Iveric granted rights to commercialise formulations of AMD treatment
15 Jul 2022 //
PMM
Iveric to develop sustained-release form of retinal disease drug
05 Jul 2022 //
FIERCEPHARMA
Optifye and DelSiTech partner on controlled-release eye drops
30 Mar 2022 //
FIERCEPHARMA
DelSiTech Enters into an Exclusive Licensing Agreement with Optifye Therapeutics
28 Mar 2022 //
PRNEWSWIRE
DelSiTech receives funding from Bill & Melinda Gates Foundation for injectables
21 May 2019 //
PHARMABIZ
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.